Andrew Jacob Silver
CIK: 0002158786
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRISPR Therapeutics AG
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Oct 26, 2026CRSP
CRISPR Therapeutics AG
Award(A)DirectStock Option (Right to Buy)
18K shares- - Oct 26, 2026CRSP
CRISPR Therapeutics AG
Award(A)DirectRestricted Stock Units
9K shares- - Oct 19, 2026CRSP
CRISPR Therapeutics AG
Award(A)DirectRestricted Stock Units
25K shares-
1-3 of 3 transactions
About Silver Andrew Jacob
Silver Andrew Jacob (SEC CIK 0002158786) files insider reports with the SEC as Chief Financial Officer of CRISPR Therapeutics AG (CRSP).
Signal8 holds 3 ownership filings by Silver Andrew Jacob (1 Form 3, 2 Form 4), filed between Oct 21, 2026 and Oct 28, 2026. Those filings report 3 transactions, from Oct 19, 2026 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Silver Andrew Jacob's filings is in BOSTON, MA.
Recent filings by Silver Andrew Jacob
Other insiders filing for CRISPR Therapeutics AG (CRSP)
- Sakhamuri Sivakesava, Chief Technical Officer
- KASINGER JAMES R., General Counsel and Secretary
- Kulkarni Samarth, Chief Executive Officer
- Patel Naimish, Chief Medical Officer
- George Simeon, Director
- Behbahani Ali, Director